A detailed history of Lazard Asset Management LLC transactions in Bioventus Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 12,616 shares of BVS stock, worth $154,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,616
Previous 12,590 0.21%
Holding current value
$154,798
Previous $72,000 108.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.73 - $11.95 $148 - $310
26 Added 0.21%
12,616 $150,000
Q2 2024

Aug 14, 2024

BUY
$3.96 - $6.93 $19,182 - $33,568
4,844 Added 62.54%
12,590 $72,000
Q1 2024

May 14, 2024

BUY
$4.33 - $5.75 $33,540 - $44,539
7,746 New
7,746 $40,000
Q2 2022

Aug 09, 2022

BUY
$6.82 - $13.82 $26,427 - $53,552
3,875 Added 123.72%
7,007 $47,000
Q1 2022

May 13, 2022

BUY
$11.65 - $15.28 $20,189 - $26,480
1,733 Added 123.87%
3,132 $44,000
Q4 2021

Feb 09, 2022

BUY
$12.37 - $16.77 $17,305 - $23,461
1,399 New
1,399 $20,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $757M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.